Combined high NEDD9 expression and E-cadherin loss correlate with poor clinical outcome in gastric cancer.

Soyoung ImYu Kyung ChoDonghoon KangGa-Yeong ShinEun Sun JungKyo Young SongSung Hak Lee Jae Myung Park

Published in: Journal of gastroenterology and hepatology (2022)

Immunohistochemical staining for NEDD9 and E-cadherin may function as a candidate prognostic marker for gastric cancer in everyday practice, especially when applied in combination.

Keyphrases

poor prognosis
primary care
healthcare
binding protein
long non coding rna